Prestige Consumer Healthcare Reports Q2 Fiscal 2026 Results
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Prestige Consumer Healthcare ( (PBH) ) is now available.
On November 6, 2025, Prestige Consumer Healthcare reported its financial results for the second quarter and first half of fiscal 2026, ending September 30, 2025. The company achieved revenues of $274.1 million in Q2, slightly below the previous year’s $283.8 million due to supply constraints in the Eye & Ear Care category. Despite this, the company exceeded its sales and earnings expectations, driven by strategic brand-building and share repurchases. The fiscal 2026 revenue outlook remains unchanged, but the adjusted diluted EPS outlook has been updated to the higher end of the previous range. The company continues to focus on rebuilding supply chain capacity for Clear Eyes and anticipates improvements in the second half of the fiscal year.
The most recent analyst rating on (PBH) stock is a Hold with a $71.00 price target. To see the full list of analyst forecasts on Prestige Consumer Healthcare stock, see the PBH Stock Forecast page.
Spark’s Take on PBH Stock
According to Spark, TipRanks’ AI Analyst, PBH is a Neutral.
Prestige Consumer Healthcare’s overall stock score reflects solid financial performance and reasonable valuation, but is tempered by bearish technical indicators and mixed earnings call sentiment. The company’s profitability and cash flow are strong, but challenges in revenue growth and supply chain issues present risks. The stock’s current technical weakness suggests caution in the short term.
To see Spark’s full report on PBH stock, click here.
More about Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc. operates in the healthcare industry, focusing on over-the-counter (OTC) healthcare products. The company is known for its diverse portfolio of leading brands, including Clear Eyes®, and emphasizes brand-building and maintaining a strong financial profile.
Average Trading Volume: 528,176
Technical Sentiment Signal: Sell
Current Market Cap: $2.98B
Learn more about PBH stock on TipRanks’ Stock Analysis page.
